Metal changes in CSF and peripheral compartments of parkinsonian patients

被引:60
作者
Bocca, B.
Alimonti, A.
Senofonte, O.
Pino, A.
Violante, N.
Petrucci, F.
Sancesario, G.
Forte, G.
机构
[1] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy
关键词
metals; CSF; blood; urine; serum; hair; Parkinson's disease;
D O I
10.1016/j.jns.2006.05.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Involvement of metals in the risk of developing Parkinson's disease (PD) has been suggested. In the present study, concentration of metals in cerebrospinal fluid (CSF), blood, serum, urine and hair of 91 PD patients and 18 controls were compared. Methods: Blood and hair were microwave digested, while CSF, serum and urine were water-diluted. Elements quantification was achieved by Inductively Coupled Plasma Atomic Emission Spectrometry and Sector Field Inductively Coupled Plasma Mass Spectrometry. Results: Some metal imbalances in PD were observed: i), in CSF, lower Fe and Si; ii), in blood, higher Ca, Cu, Fe, Mg and Zn; iii), in serum, lower Al and Cu; iv), in urine, lower Al and Mn, higher Ca and Fe; and v), in hair, lower Fe. The ROC analysis suggested that blood Ca, Fe, Mg and Zn were the best discriminators between PD and controls. In addition, hair Ca and Mg were at least 1.5 times higher in females than in males of patients and controls. A decrement with age of patients in hair and urine Ca and, with less extent, in urine Si was observed. Magnesium concentration in CSF decreased with the duration and severity of the disease. Elements were not influenced by the type of antiparkinsonian therapy. Conclusions: Variation in elements with the disease do not exclude their involvement in the neurodegeneration of PD. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 48 条
[1]   INVESTIGATION OF ELEMENTAL MODELS IN SENILE DEMENTIA AND DEPRESSIVES USING NEUTRON-ACTIVATION ANALYSIS [J].
AKANLE, OA ;
SPYROU, NM ;
DAMYANOVA, AA ;
SHAW, DM ;
ALI, L .
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES, 1987, 113 (02) :405-416
[2]   Manganese: Brain transport and emerging research needs [J].
Aschner, M .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 :429-432
[3]  
BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231
[4]  
BIRCHALL JD, 1988, CLIN CHEM, V34, P265
[5]   Quantification of trace elements by sector field inductively coupled plasma mass spectrometry in urine, serum, blood and cerebrospinal fluid of patients with Parkinson's disease [J].
Bocca, B ;
Alimonti, A ;
Petrucci, F ;
Violante, N ;
Sancesario, G ;
Forte, G ;
Senofonte, O .
SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY, 2004, 59 (04) :559-566
[6]   PERIPHERAL IRON-METABOLISM IN PATIENTS WITH PARKINSONS-DISEASE [J].
CABRERAVALDIVIA, F ;
JIMENEZJIMENEZ, FJ ;
MOLINA, JA ;
FERNANDEZCALLE, P ;
VAZQUEZ, A ;
CANIZARESLIEBANA, F ;
LARUMBELOBALDE, S ;
AYUSOPERALTA, L ;
RABASA, M ;
CODOCEO, R .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 125 (01) :82-86
[7]  
Daniel S E, 1993, J Neural Transm Suppl, V39, P165
[8]   INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
WELLS, FR ;
LEES, AJ ;
AGID, F ;
AGID, Y ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) :1830-1836
[9]   ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE-METALS IN PARKINSONS-DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA [J].
DEXTER, DT ;
CARAYON, A ;
JAVOYAGID, F ;
AGID, Y ;
WELLS, FR ;
DANIEL, SE ;
LEES, AJ ;
JENNER, P ;
MARSDEN, CD .
BRAIN, 1991, 114 :1953-1975
[10]  
FLATEN TP, 1987, TRACE ELEM MED, V4, P179